Global Cancer Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 151941
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.

Scope of the Report:

North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. 

The Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.

The worldwide market for Cancer Diagnostics is expected to grow at a CAGR of roughly 12.7% over the next five years, will reach 18400 million US$ in 2023, from 8990 million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Cancer Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Becton, Dickinson and Company

GE Healthcare

Abbott

Roche

Thermo Fisher Scientific, Inc.

Agilent Technologies, Inc.

Illumina, Inc.

Siemens Healthcare

C.R. Bard, Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Platform-based

Instrument-based

Market Segment by Applications, can be divided into

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Others

There are 15 Chapters to deeply display the global Cancer Diagnostics market.

Chapter 1, to describe Cancer Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Diagnostics, with sales, revenue, and price of Cancer Diagnostics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Diagnostics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Cancer Diagnostics Introduction

1.2 Market Analysis by Type

1.2.1 Platform-based

1.2.2 Instrument-based

1.3 Market Analysis by Applications

1.3.1 Breast Cancer

1.3.2 Lung Cancer

1.3.3 Colorectal Cancer

1.3.4 Melanoma

1.3.5 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Becton, Dickinson and Company

2.1.1 Business Overview

2.1.2 Cancer Diagnostics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Becton, Dickinson and Company Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 GE Healthcare

2.2.1 Business Overview

2.2.2 Cancer Diagnostics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GE Healthcare Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Abbott

2.3.1 Business Overview

2.3.2 Cancer Diagnostics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Abbott Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Roche

2.4.1 Business Overview

2.4.2 Cancer Diagnostics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Roche Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Thermo Fisher Scientific, Inc.

2.5.1 Business Overview

2.5.2 Cancer Diagnostics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Agilent Technologies, Inc.

2.6.1 Business Overview

2.6.2 Cancer Diagnostics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Agilent Technologies, Inc. Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Illumina, Inc.

2.7.1 Business Overview

2.7.2 Cancer Diagnostics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Illumina, Inc. Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Siemens Healthcare

2.8.1 Business Overview

2.8.2 Cancer Diagnostics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Siemens Healthcare Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 C.R. Bard, Inc.

2.9.1 Business Overview

2.9.2 Cancer Diagnostics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 C.R. Bard, Inc. Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cancer Diagnostics Manufacturer Market Share in 2017

3.3.2 Top 6 Cancer Diagnostics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cancer Diagnostics Market Analysis by Regions

4.1 Global Cancer Diagnostics Sales, Revenue and Market Share by Regions

4.1.1 Global Cancer Diagnostics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cancer Diagnostics Revenue and Market Share by Regions (2013-2018)

4.2 North America Cancer Diagnostics Sales and Growth Rate (2013-2018)

4.3 Europe Cancer Diagnostics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer Diagnostics Sales and Growth Rate (2013-2018)

4.5 South America Cancer Diagnostics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer Diagnostics Sales and Growth Rate (2013-2018)

5 North America Cancer Diagnostics by Countries

5.1 North America Cancer Diagnostics Sales, Revenue and Market Share by Countries

5.1.1 North America Cancer Diagnostics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)

5.2 United States Cancer Diagnostics Sales and Growth Rate (2013-2018)

5.3 Canada Cancer Diagnostics Sales and Growth Rate (2013-2018)

5.4 Mexico Cancer Diagnostics Sales and Growth Rate (2013-2018)

6 Europe Cancer Diagnostics by Countries

6.1 Europe Cancer Diagnostics Sales, Revenue and Market Share by Countries

6.1.1 Europe Cancer Diagnostics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cancer Diagnostics Sales and Growth Rate (2013-2018)

6.3 UK Cancer Diagnostics Sales and Growth Rate (2013-2018)

6.4 France Cancer Diagnostics Sales and Growth Rate (2013-2018)

6.5 Russia Cancer Diagnostics Sales and Growth Rate (2013-2018)

6.6 Italy Cancer Diagnostics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cancer Diagnostics by Countries

7.1 Asia-Pacific Cancer Diagnostics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cancer Diagnostics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)

7.2 China Cancer Diagnostics Sales and Growth Rate (2013-2018)

7.3 Japan Cancer Diagnostics Sales and Growth Rate (2013-2018)

7.4 Korea Cancer Diagnostics Sales and Growth Rate (2013-2018)

7.5 India Cancer Diagnostics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer Diagnostics Sales and Growth Rate (2013-2018)

8 South America Cancer Diagnostics by Countries

8.1 South America Cancer Diagnostics Sales, Revenue and Market Share by Countries

8.1.1 South America Cancer Diagnostics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cancer Diagnostics Sales and Growth Rate (2013-2018)

8.3 Argentina Cancer Diagnostics Sales and Growth Rate (2013-2018)

8.4 Colombia Cancer Diagnostics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cancer Diagnostics by Countries

9.1 Middle East and Africa Cancer Diagnostics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cancer Diagnostics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cancer Diagnostics Sales and Growth Rate (2013-2018)

9.3 UAE Cancer Diagnostics Sales and Growth Rate (2013-2018)

9.4 Egypt Cancer Diagnostics Sales and Growth Rate (2013-2018)

9.5 Nigeria Cancer Diagnostics Sales and Growth Rate (2013-2018)

9.6 South Africa Cancer Diagnostics Sales and Growth Rate (2013-2018)

10 Global Cancer Diagnostics Market Segment by Type

10.1 Global Cancer Diagnostics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cancer Diagnostics Sales and Market Share by Type (2013-2018)

10.1.2 Global Cancer Diagnostics Revenue and Market Share by Type (2013-2018)

10.2 Platform-based Sales Growth and Price

10.2.1 Global Platform-based Sales Growth (2013-2018)

10.2.2 Global Platform-based Price (2013-2018)

10.3 Instrument-based Sales Growth and Price

10.3.1 Global Instrument-based Sales Growth (2013-2018)

10.3.2 Global Instrument-based Price (2013-2018)

11 Global Cancer Diagnostics Market Segment by Application

11.1 Global Cancer Diagnostics Sales Market Share by Application (2013-2018)

11.2 Breast Cancer Sales Growth (2013-2018)

11.3 Lung Cancer Sales Growth (2013-2018)

11.4 Colorectal Cancer Sales Growth (2013-2018)

11.5 Melanoma Sales Growth (2013-2018)

11.6 Others Sales Growth (2013-2018)

12 Cancer Diagnostics Market Forecast (2018-2023)

12.1 Global Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2023)

12.2 Cancer Diagnostics Market Forecast by Regions (2018-2023)

12.2.1 North America Cancer Diagnostics Market Forecast (2018-2023)

12.2.2 Europe Cancer Diagnostics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cancer Diagnostics Market Forecast (2018-2023)

12.2.4 South America Cancer Diagnostics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cancer Diagnostics Market Forecast (2018-2023)

12.3 Cancer Diagnostics Market Forecast by Type (2018-2023)

12.3.1 Global Cancer Diagnostics Sales Forecast by Type (2018-2023)

12.3.2 Global Cancer Diagnostics Market Share Forecast by Type (2018-2023)

12.4 Cancer Diagnostics Market Forecast by Application (2018-2023)

12.4.1 Global Cancer Diagnostics Sales Forecast by Application (2018-2023)

12.4.2 Global Cancer Diagnostics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cancer Diagnostics Picture

Table Product Specifications of Cancer Diagnostics

Figure Global Sales Market Share of Cancer Diagnostics by Types in 2017

Ta

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery